We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cellcast Plc | LSE:CLTV | London | Ordinary Share | GB00B0GWFM68 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.25 | 1.00 | 1.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMCLTV
RNS Number : 1264V
Cellcast plc
25 January 2017
25 January 2017
Cellcast plc
("Cellcast", "the Group" or "the Company")
Holdings in company
Cellcast plc (AIM: CLTV) announces that on 25 January 2017 it received notification from Atlas Group of Companies Limited ("Atlas") that, following a purchase of 1,400,000 shares in the Company, Atlas now has a total beneficial interest in 14,723,135 ordinary shares in Cellcast, equivalent to 18.99% of the Company's issued ordinary share capital.
For further information:
Cellcast plc 020 3376 9420 Andrew Wilson, Chief Executive Allenby Capital Limited (Nominated Adviser and Broker) 0203 328 5656 Nick Naylor / James Reeve
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLSELFIIFWSEFF
(END) Dow Jones Newswires
January 25, 2017 10:20 ET (15:20 GMT)
1 Year Cellcast Chart |
1 Month Cellcast Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
